IP Library Patent Application 15390452
Patent Application
App. No. 15/390,452

DETERMINING A TYPE OF DISORDERED BREATHING

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
15/390,452
Abstract

A device is disclosed that can determine a type of disordered breathing in a patient. The device can include a number of contacts adapted to make contact with portions of an oral cavity of a patient and configured to provide a first signal indicative of one or more states of the patient's upper airway. The device can also include a control circuit configured to determine a type of disordered breathing in the patient based, at least in part, on the first signal.

Claims (49)

1 . A device comprising:

a number of contacts adapted to make contact with portions of an oral cavity of a patient and configured to provide a first signal indicative of one or more states of the patient's upper airway; and

a control circuit coupled to the contacts and configured to determine a type of disordered breathing in the patient based, at least in part, on the first signal.

2 . The device of claim 1 , wherein the determined type of disordered breathing is one of a breathing obstruction, central nervous system (CNS) depression, and hyperventilation.

3 . The device of claim 1 , wherein a portion of two of the contacts are adapted to be positioned posterior to a last molar location of the patient.

4 . The device of claim 1 , wherein the control circuit is configured to selectively provide electrical stimulation to a portion of the patient's upper airway, via the number of contacts, based on the determined type of disordered breathing.

5 . The device of claim 4 , wherein the control circuit is configured to:

electrically stimulate the portion of the patient's upper airway based on the disordered breathing comprising a breathing obstruction; and

withhold electrical stimulation of the portion of the patient's upper airway based on the disordered breathing consisting of central nervous system (CNS) depression.

6 . The device of claim 5 , wherein the electrical stimulation is configured to target the patient's Palatoglossus muscle and to avoid targeting the patient's Hypoglossal nerve.

7 . The device of claim 1 , wherein the control circuit is configured to:

indicate the type of disordered breathing as a breathing obstruction based on a magnitude of the first signal decreasing during each of at least two successive respiratory cycles of the patient; and

indicate the type of disordered breathing as a central nervous system (CNS) depression based on the magnitude of the first signal remaining substantially constant for a number of respiratory cycles of the patient.

8 . The device of claim 1 , wherein the control circuit is configured to:

indicate the type of disordered breathing as a breathing obstruction based on a positive slope of the first signal decreasing during each of at least two successive respiratory cycles of the patient; and

indicate the type of disordered breathing as a central nervous system (CNS) depression based on the magnitude of the first signal remaining substantially constant for a number of respiratory cycles of the patient.

9 . The device of claim 1 , wherein the control circuit is configured to:

indicate the type of disordered breathing as a breathing obstruction based on a magnitude of the first signal varying by more than an amount during a time period; and

indicate the type of disordered breathing as a central nervous system (CNS) depression based on a magnitude of the first signal remaining relatively constant for the time period.

10 . The device of claim 1 , wherein:

the device comprises a sensor configured to provide a second signal indicating an amount of airflow in the patient's upper airway; and

the control circuit is configured to determine the type of disordered breathing in the patient based, at least in part, on the first signal and the second signal.

11 . The device of claim 10 , wherein the first signal is indicative of at least one of electrical activity in the patient's upper airway, movement of the patient's upper airway, and a change in the patient's respiration rate.

12 . The device of claim 11 , wherein the sensor comprises a thermistor.

13 . A method comprising:

receiving, from a number of contacts positioned within an oral cavity of a patient, a first signal indicative of one or more states of the patient's upper airway; and

determining a type of disordered breathing in the patient based, at least in part, on the first signal.

14 . The method of claim 13 , wherein the determined type of disordered breathing is one of a breathing obstruction, central nervous system (CNS) depression, and hyperventilation.

15 . The method of claim 13 , wherein a portion of two of the contacts are adapted to be positioned posterior to a last molar location of the patient.

16 . The method of claim 13 , further comprising:

selectively providing electrical stimulation to a portion of the patient's upper airway, via the number of contacts, based on the determined type of disordered breathing.

17 . The method of claim 16 , further comprising:

electrically stimulating the portion of the patient's upper airway based on the disordered breathing comprising a breathing obstruction; and

withholding electrical stimulation of the portion of the patient's upper airway based on the disordered breathing consisting of central nervous system (CNS) depression.

18 . The method of claim 16 , wherein the electrical stimulation is configured to target the patient's Palatoglossus muscle and to avoid targeting the patient's Hypoglossal nerve.

19 . The method of claim 13 , further comprising:

indicating the type of disordered breathing as a breathing obstruction based on a magnitude of the first signal decreasing during each of at least two successive respiratory cycles of the patient; and

indicating the type of disordered breathing as a central nervous system (CNS) depression based on the magnitude of the first signal remaining substantially constant for a number of respiratory cycles of the patient.

20 . The method of claim 13 , further comprising:

indicating the type of disordered breathing as a breathing obstruction based on a positive slope of the first signal decreasing during each of at least two successive respiratory cycles of the patient; and

indicating the type of disordered breathing as a central nervous system (CNS) depression based on the magnitude of the first signal remaining substantially constant for a number of respiratory cycles of the patient.

21 . The method of claim 13 , further comprising:

indicating the type of disordered breathing as a breathing obstruction based on a magnitude of the first signal varying by more than an amount during a time period; and

indicating the type of disordered breathing as a central nervous system (CNS) depression based on a magnitude of the first signal remaining relatively constant for the time period.

22 . The method of claim 13 , further comprising:

receiving, from a sensor, a second signal indicating an amount of airflow in the patient's upper airway; and

determining the type of disordered breathing in the patient based, at least in part, on the first signal and the second signal.

23 . The method of claim 22 , wherein the first signal is indicative of at least one member of the group consisting of electrical activity in the patient's upper airway, movement of the patient's upper airway, and a change in the patient's respiration rate.

24 . The method of claim 22 , wherein the sensor comprises a thermistor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2017
From: KENT, STEVEN THOMAS; KENT, HAROLD BYRON; FISHER, CHRISTOPHER; YOUNG, RONALD W.; PULDON, KARENA YADIRA; KENT, ROBERT DOUGLAS; HARTER, LAURENCE WYLIE
To: INVICTA MEDICAL, INC.
Reel/Frame 041136/0112 →